Trials / Completed
CompletedNCT03830359
Efficacy, Safety of T2769 in Dry Eye Disease
Efficacy and Safety Assessment of T2769 in Patients With Moderate to Severe Dry Eye Syndrome
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 62 (actual)
- Sponsor
- Laboratoires Thea · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Efficacy of T2769 in Dry Eye Desease
Detailed description
Multicenter and open study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | T2769 | At least 55 enrolled patients for at least 50 evaluable patients treated by T2769 for 42 days |
Timeline
- Start date
- 2018-09-01
- Primary completion
- 2019-02-18
- Completion
- 2019-02-18
- First posted
- 2019-02-05
- Last updated
- 2022-03-16
- Results posted
- 2022-03-04
Locations
3 sites across 1 country: Tunisia
Source: ClinicalTrials.gov record NCT03830359. Inclusion in this directory is not an endorsement.